Moderna

(NASDAQ) MRNA

Current Price$67.38

Market Cap$23.71B

Since IPO (2018)+262%

5 Year-69%

1 Year+144%

1 Month+41%

Moderna Financials at a Glance

Market Cap

$23.71B

Revenue (TTM)

$2.23B

Net Income (TTM)

-$3.19B

EPS (TTM)

-$8.15

P/E Ratio

-7.33

Dividend

$0.00

Beta (Volatility)

1.31 (Average)

Dividend

$0.00

Beta (Volatility)

1.31 (Average)

Price

$67.38

Volume

550,466

Open

$59.43

Price

$67.38

Volume

550,466

Open

$59.43

Previous Close

$67.38

Daily Range

$59.27 - $69.27

52-Week Range

$22.28 - $69.27

Estimated Earnings Date

Jul 31, 2026

Dividend

$0.00

Beta (Volatility)

1.31 (Average)

Price

$67.38

Volume

550,466

Open

$59.43

Previous Close

$67.38

Daily Range

$59.27 - $69.27

52-Week Range

$22.28 - $69.27

Estimated Earnings Date

Jul 31, 2026

MRNA News

This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst

Prosper Junior BakinyJun 26, 2026

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

James HalleyJun 20, 2026

These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead

Prosper Junior BakinyJun 18, 2026

Woman using gloves to hold up and inspect a red pill.

Page 1

MRNA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Moderna

Industry

Biotechnology

Sector

Health Care

Employees

4,700

CEO

Stéphane Bancel, MBA

Website

www.modernatx.com

Headquarters

Cambridge, MA 02142, US

MRNA Financials

Key Financial Metrics (TTM)

Gross Margin

-13.89%

Operating Margin

-153.35%

Net Income Margin

-143.55%

Return on Equity

-36.73%

Return on Capital

-29.09%

Return on Assets

-27.80%

Earnings Yield

-13.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$23.71B

Shares Outstanding

396.79M

Volume

550.47K

Avg. Volume

7.06M

Financials (TTM)

Gross Profit

-$309.00M

Operating Income

-$3.41B

EBITDA

-$2.89B

Operating Cash Flow

-$1.45B

Capital Expenditure

-$137.00M

Free Cash Flow

-$1.58B

Cash & ST Invst.

$5.21B

Total Debt

$1.30B

Moderna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$389.00M

+263.6%

Gross Profit

-$566.00M

-3429.4%

Gross Margin

-1.46%

N/A

Market Cap

$23.71B

N/A

Market Cap/Employee

$4.09M

N/A

Employees

5,800

N/A

Net Income

-$1.34B

-38.3%

EBITDA

-$1.26B

-36.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$5.21B

-12.9%

Total Debt

$1.30B

+74.2%

Accounts Receivable

$147.00M

-52.0%

Inventory

$146.00M

+14.1%

Long Term Debt

$1.25B

+77.8%

Short Term Debt

$50.00M

+16.3%

Return on Assets

-27.80%

N/A

Return on Invested Capital

-37.52%

N/A

Free Cash Flow

-$692.00M

+40.5%

Operating Cash Flow

-$630.00M

+39.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

JAZZJazz Pharmaceuticals plc

JAZZJazz Pharmaceuticals plc$230.02+1.69%

EXELExelixis, Inc.

EXELExelixis, Inc.$54.77+2.89%

BBIOBridgeBio Pharma, Inc.

BBIOBridgeBio Pharma, Inc.$70.24+0.79%

MDGLMadrigal Pharmaceuticals, Inc.

MDGLMadrigal Pharmaceuticals, Inc.$512.65-0.22%

BMRNBioMarin Pharmaceutical Inc.

BMRNBioMarin Pharmaceutical Inc.$59.00+2.88%

TECHBio-Techne Corporation

TECHBio-Techne Corporation$71.00+0.42%

HALOHalozyme Therapeutics, Inc.

HALOHalozyme Therapeutics, Inc.$74.96+3.20%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

HLHecla Mining

HLHecla Mining$15.54+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.88+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

WENWendy's

WENWendy's$7.80+0.06%

Questions About MRNA

What is the current price of Moderna?

Moderna is trading at $67.38 per share.

What is the 52-week range for Moderna?

Over the past 52 weeks, Moderna has traded between $22.28 and $69.27.

How much debt does Moderna have?

As of the most recent reporting period, Moderna reported total debt of $1.30B.

How much cash does Moderna have on hand?

Moderna reported $1.91B in cash and cash equivalents in its most recent financial results.

What is Moderna’s dividend yield?

Moderna does not currently have a dividend yield.

Moderna

Moderna Financials at a Glance

MRNA News

This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead

Biotech vs. Pharma: What's the Difference?

Does Moderna Need to Start Making Money?

Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth

MRNA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Moderna

MRNA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Moderna Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MRNA

What is the current price of Moderna?

What is the 52-week range for Moderna?

How much debt does Moderna have?

How much cash does Moderna have on hand?

What is Moderna’s dividend yield?

Premium Investing Services